A Randomized, Open-label, Crossover, Phase 1 Study to Evaluate Pharmacokinetics and Safety of Irbesartan/Amlodipine High Fixed Dose Combination in Comparison With Co-administration of Mono Compounds in Healthy Volunteers
Latest Information Update: 22 Aug 2023
At a glance
- Drugs Amlodipine/irbesartan (Primary) ; Amlodipine; Irbesartan
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Handok Inc
Most Recent Events
- 22 Aug 2023 New trial record